Wednesday, June 19, 2013

Stalking/ Farm Bill/ Immigration


“Stacy Lear claims she was stalked by Carrie Jamrogowicz beginning in 2002. In February 2012, Lear sought and obtained a temporary order of protection against Jamrogowicz in a civil action. Subsequently, Lear obtained a “no contact” order against Jamrogowicz in a criminal action. Jamrogowicz moved to have the civil action dismissed with prejudice and Lear moved to have the civil action dismissed without prejudice. The District Court granted Lear’s motion and dismissed the civil action without prejudice. Jamrogowicz appeals. We affirm.”


“CBO estimates that, by 2023, enacting S. 744 would lead to a net increase of 10.4 million in the number of people residing in the United States, compared with the number of people projected under current law. That net increase comprises an increase of about 10.4 million permanent residents; an increase of about 1.6 million temporary workers and their dependents; and a decrease of about 1.6 million unauthorized residents. (CBO estimates that about 8 million unauthorized residents would initially gain legal status under the bill, but that change in status would not affect the size of the U.S. population.)”

Tuesday, June 18, 2013

Government Surveillance/ Anti-Abortion Bill/ Women in the Military



“Prohibits the abortion from being performed if the probable post-fertilization age of the unborn child is 20 weeks or greater. Makes an exception where necessary to save the life of a pregnant woman whose life is endangered by a physical disorder, illness, or injury, excluding psychological or emotional conditions…. Prescribes penalties for violations. Bars prosecution of a woman upon whom an abortion is performed in violation of this Act, but authorizes such a woman or the father or maternal grandparent of the unborn child to obtain appropriate relief through a civil action.”

Monday, June 17, 2013

Lower BAC/ Equal Pay/ Generic Drugs


As described in chapter 4, laboratory studies have shown that driving-related performance is degraded at BAC levels as low as 0.01, and epidemiological studies employing crash data have shown significantly elevated crash risk at BAC levels near 0.05. Lowering per se BAC limits has been associated with reductions in impaired driving crashes and fatalities. For example, 14 independent studies conducted in the United States found that lowering the BAC limit from 0.10 to 0.08 resulted in reductions in alcohol-related crashes, fatalities, or injuries of 5–16 percent (Fell and Voas 2006, 233–43). Other studies have found similar results (for example, Dee 2001, 111–28; Shults and others 2001, 66–88; Voas, Tippetts, and Fell 2000, 483–92). In 2012, the CDC listed 0.08 per se BAC laws among the “top 20 violence and injury practice innovations since 1992” (Kress and others 2012, 257–63).27


“Respondent Solvay Pharmaceuticals obtained a patent for its approved brand-name drug AndroGel. Subsequently, respondents Actavis and Paddock filed applications for generic drugs modeled afterAndroGel and certified under paragraph IV that Solvay’s patent was invalid and that their drugs did not infringe it. Solvay sued Actavis and Paddock, claiming patent infringement. See 35 U. S. C. §271(e)(2)(A). The FDA eventually approved Actavis’ generic product, but instead of bringing its drug to market, Actavis entered into a “reverse payment” settlement agreement with Solvay, agreeing not to bring its generic to market for a specified number of years and agreeing to promote AndroGel to doctors in exchange for millions of dollars. Paddock made a similar agreement with Solvay, as did respondent Par, another manufacturer aligned in the patent litigationwith Paddock.”